External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home AAIC 2023
Roche and Genentech at

AAIC 2023

July 16 - July 20
Amsterdam, Netherlands / Virtual (Hybrid)
aaic.alz.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
02:15 PM
Duration 75mins Hall 5
GRADUATE I and II: Revisiting the Key Findings From Two Phase III Studies Evaluating the Efficacy and Safety of Subcutaneous Gantenerumab in Early Alzheimer’s Disease
Lane C, Smith J, Perry RJ, Grimmer T, Lansdall CJ, Voyle N, Delmar P, Bittner T, Klein G, Schwab D, Schneider A, Salloway S, Cummings JL, Baudler M, Fontoura P, Doody RS
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 75mins Hall 5
GRADUATE I and II: Subgroup analyses from two Phase III studies evaluating the efficacy and safety of subcutaneous gantenerumab in early Alzheimer’s disease (AD)
Thanasopoulou A, Lane C, Delmar P, Voyle N, Huang Z, Schwab D, Fox NC, Smith J, Doody RS
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 75mins Hall 5
GRADUATE I and II: Subgroup analysis and correlations of biomarkers
Bittner T, Belousov A, Lane C, Klein G, Tonietto M, Illiano V, Blennow K, Barkhof F, Smith J, Doody RS
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 75mins Elicium 2
A perspective on data sharing from potentially registrational trials
Sink KM, Narburgh L, Hu N, Tucker K, Doody RS
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
04:15 PM
Duration 75mins Elicium 2
Statistical innovations in the API ADAD Colombia trial: a randomized, double-blind, placebo-controlled, parallel-group study in cognitively unimpaired PSEN1 E280A mutation carriers evaluating efficacy and safety of crenezumab
Hu N, Mackey H, Doody RS, Lopera F, Tariot PN, Reiman EM, Thomas RG, Langbaum JB, Sink KM
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:15 AM
Duration 75mins Hall 5
Observations on Biomarkers in Roche Abeta-targeting Monoclonal Antibody Trials
Doody RS
Neuroscience | Alzheimer Disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.